Decade in review--heart failure: 10 Years of progress in HF research--what have we learned?

Area of Science:

• Cardiology and cardiovascular medicine.
• Heart failure research and clinical practice.

Background:

• Heart failure (HF) remains a significant global health challenge.
• Progress in managing HF has been uneven across different subtypes.

Purpose of the Study:

• To review the top 10 advances in heart failure over the last decade.
• To identify areas of significant progress and highlight areas needing further development.

Main Methods:

• A comprehensive review of major advancements in heart failure therapies and devices.
• Analysis of trends and outcomes in HF management over a ten-year period.

Main Results:

• Significant progress in pharmacological therapies and device indications for HF with reduced ejection fraction.
• Limited progress noted in acute HF and HF with preserved ejection fraction management.
• Emerging role of biomarkers and advanced devices in HF prevention and treatment.

Conclusions:

• The past decade has seen notable therapeutic and device-based improvements for specific HF populations.
• Future HF management will likely integrate advanced biomarkers and devices for personalized treatment strategies.
• Continued research is crucial for addressing unmet needs in acute HF and HF with preserved ejection fraction.